Comparative Efficacy and Safety of First-Line Treatment With Atezolizumab/Bevacizumab vs. Tyrosine-kinase Inhibitors in Patients With Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
阿特珠单抗/贝伐珠单抗与酪氨酸激酶抑制剂一线治疗不可切除肝细胞癌患者的疗效和安全性比较:系统评价和荟萃分析
期刊:Journal of Clinical and Experimental Hepatology
影响因子:3.2
doi:10.1016/j.jceh.2025.102633
Saowapa, Sakditad; Polpichai, Natchaya; Danpanichkul, Pojsakorn; Bernal, Romelia B; Siladech, Pharit; Tijani, Lukman; Ng, Kenrick; Wong, Yu J; Choudhury, Ashok; Saokaew, Surasak; Liangpunsakul, Suthat; Kaewdech, Apichat